Patent Review Reforms Still Getting Tweaked In Advance Of House Vote
This article was originally published in The Pink Sheet Daily
Executive Summary
Innovation Act clears committee with language aimed at curbing stock manipulation, but Rx industry withholds support in effort to obtain even more limits on inter partes review process.